文献速递腹部MR

HBV患者中大型高分化肝细胞癌:钆塞酸二钠增强MR影像特征与预后

Large well-differentiated hepatocellular carcinoma in patients with HBV: gadoxetic acid-enhanced MR imaging features and prognosis.
PubMed 文献 · Eur Radiol · 2025-09-12

这项回顾性研究纳入182例HBV相关肝细胞癌(≥3 cm)患者,31例为大型高分化肝细胞癌、151例为典型肝细胞癌,评估钆塞酸二钠增强MR特征与预后。结果显示,移行期高信号和镶嵌结构与大高分化肝细胞癌相关,门静脉癌栓和镶嵌结构与无复发生存及总生存相关。

要点

  • 大型高分化肝细胞癌在移行期更常表现为廓清(32% vs 17%)或不廓清(26% vs 11%)。
  • 门脉期病灶-肝信号强度比在大型高分化肝细胞癌中更高(1.04±0.21 vs 0.85±0.26)。
  • 移行期高信号(OR 3.186)和镶嵌结构(OR 0.215)是大型高分化肝细胞癌的独立影像预测因子。

核心结论

  • 移行期高信号和镶嵌结构与大型高分化肝细胞癌相关;门静脉癌栓和镶嵌结构与HBV相关肝细胞癌(≥3 cm)患者的RFS和OS显著相关。

研究设计与样本

  • 回顾性研究纳入182例接受钆塞酸二钠增强MR扫描及手术切除的HBV相关肝细胞癌(≥3 cm)患者,其中31例定义为大型高分化肝细胞癌、151例为典型肝细胞癌;评估临床病理特征和钆塞酸二钠增强MR影像特征,采用Kaplan-Meier法和Cox比例风险模型分析无复发生存和总生存。

关键影像表现/征象

  • 大型高分化肝细胞癌微血管侵犯发生率更低(29% vs 56%,p=0.021),且无巨梁-块状型或脂肪性肝炎型亚型。
  • 大型高分化肝细胞癌更常见移行期廓清(32% vs 17%,p=0.004)或无廓清(26% vs 11%,p=0.004)。
  • 大型高分化肝细胞癌门脉期病灶-肝信号强度比显著更高(1.04±0.21 vs 0.85±0.26,p<0.001)。

诊断标准与关键数值

  • 移行期高信号与大型高分化肝细胞癌独立相关(OR 3.186,p=0.010)。
  • 镶嵌结构与大型高分化肝细胞癌独立相关(OR 0.215,p=0.004)。
  • 门静脉癌栓是RFS较差的独立预测因子(HR 0.265,p=0.024)。
  • 门静脉癌栓(HR 0.396,p=0.023)和镶嵌结构(HR 0.286,p=0.002)与OS较差相关。

临床应用与阅片要点

  • 移行期高信号和镶嵌结构可用于提示大型高分化肝细胞癌。
  • 门静脉癌栓和镶嵌结构可用于评估HBV相关肝细胞癌(≥3 cm)患者的预后。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To explore the gadoxetic acid-enhanced MR imaging features and prognosis of large well-differentiated hepatocellular carcinoma (LWDHCC) (≥ 3 cm) in patients with HBV.

MATERIALS AND METHODS: One hundred and eighty-two patients with HBV-related HCC (≥ 3 cm) who underwent gadoxetic acid-enhanced MR scanning and surgical resection were included in this retrospective study, 31 were defined as LWDHCC and 151 as typical HCC. Clinicopathologic characteristics and gadoxetic acid-enhanced MR imaging features were evaluated. The Kaplan-Meier method and Cox proportional hazards model were used to analyze recurrence-free survival (RFS), overall survival (OS).

RESULTS: LWDHCCs had a lower incidence of microvascular invasion (29% vs 56%, p = 0.021), and none of them were classified as macrotrabecular-massive or steatohepatitic subtype. LWDHCCs showed transitional-phase (TP) washout more frequently (32% vs 17%, p = 0.004) or did not washout (26% vs 11%, p = 0.004). Lesion-to-liver signal intensity ratio during the portal phase of LWDHCC was significantly higher (1.04 ± 0.21 vs 0.85 ± 0.26, p < 0.001). TP hyperintensity (odds ratio, 3.186; p = 0.010) and mosaic architecture (odds ratio, 0.215; p = 0.004) were independent imaging predictors associated with LWDHCC. Portal vein tumor thrombosis (PVTT) (hazard ratio [HR] 0.265, p = 0.024) was an independent predictor of poorer RFS, while PVTT (HR 0.396, p = 0.023) and mosaic architecture (HR 0.286, p = 0.002) were linked to poorer OS.

CONCLUSION: TP hyperintensity and mosaic architecture were associated with LWDHCC. PVTT and mosaic architecture were significantly associated with RFS and OS in patients with HBV-related HCC (≥ 3 cm).

KEY POINTS: Question Gadoxetic acid-enhanced MR imaging features and prognosis of large and well-differentiated HBV-related HCC are unknown. Findings Transitional phase hyperintensity and mosaic architecture were associated with large well-differentiated HCC, portal vein tumor thrombus, and mosaic architecture were associated with prognosis. Clinical relevance The study provides clinicians with a more robust diagnostic and prognostic framework for managing patients with HCC ≥ 3.0 cm, and is helpful to understand the pathogenesis of large well-differentiated HCC, which may not necessarily be multi-step carcinogenesis.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Tao Y, Song M, Zhang H, et al. Large well-differentiated hepatocellular carcinoma in patients with HBV: gadoxetic acid-enhanced MR imaging features and prognosis. Eur Radiol. 2025. PMID: 40940571. doi:10.1007/s00330-025-11994-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。